Edward Chu
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 90
- Cancer Treatment and Pharmacology 45
- Colorectal Cancer Surgical Treatments 25
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 18
- Molecular Biology top 2%
- Biochemical and Molecular Research 32
- Toxicology top 2%
-
- Palliative Care and End-of-Life Issues 22
-
- Gastric Cancer Management and Outcomes 20
-
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Co-authors
- Vincent T. DeVitaCarmen J. AllegraJames J. LeeJohn C. SchmitzJan H. BeumerJ C DrakeFrank MaleyS Zinn
- Journals
- Clinical Colorectal Cancer (56 papers)Journal of Clinical Oncology (21 papers)Cancer Chemotherapy and Pharmacology (10 papers)
- Partner nations
- United StatesChinaUkraine
In The Last Decade
Edward Chu
244 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Oncology 3.8k
- Cancer Research 800
- Molecular Biology 3.5k
- Pathology and Forensic Medicine 705
- Toxicology 110
Countries citing papers authored by Edward Chu
This map shows the geographic impact of Edward Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Chu more than expected).
Fields of papers citing papers by Edward Chu
This network shows the impact of papers produced by Edward Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Chu. The network helps show where Edward Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2021 | 63 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 10 | |
| 8 | 2015 | 4 | |
| 9 | 2014 | 5 | |
| 10 | 2014 | 54 | |
| 11 | 2014 | 47 | |
| 12 | 2010 | 19 | |
| 13 | 2007 | 135 | |
| 14 | Yale cancer center: Past, present, and future | 2006 | 1 |
| 15 | PHY906 as a broad-spectrum enhancer in cancer therapy: Clinical and preclinical results in hepatocellular carcinoma | 2006 | 15 |
| 16 | 2003 | 86 | |
| 17 | 2002 | 100 | |
| 18 | 1999 | 80 | |
| 19 | 1994 | 18 | |
| 20 | The importance of early diagnosis of bronchogenic carcinoma: clinical analysis of 236 cases of bronchogenic cancer in the municipality of Shanghai. | 1959 | 1 |
About Edward Chu
Edward Chu is a scholar working on Oncology, Hepatology and Cancer Research, having authored 251 papers that have together received 8.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (90 papers), Cancer Treatment and Pharmacology (45 papers), Biochemical and Molecular Research (32 papers), Colorectal Cancer Surgical Treatments (25 papers), Palliative Care and End-of-Life Issues (22 papers), Gastric Cancer Management and Outcomes (20 papers), Cancer, Hypoxia, and Metabolism (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (18 papers). The work is most often cited by research in Oncology (3.8k citations), Cancer Research (800 citations) and Molecular Biology (3.5k citations). Edward Chu has collaborated with scholars based in United States, China and Ukraine. Frequent co-authors include Vincent T. DeVita, Carmen J. Allegra, James J. Lee, John C. Schmitz, Jan H. Beumer, J C Drake, Frank Maley, S Zinn, Jingfang Ju and Yael Schenker. Their work appears in journals such as Clinical Colorectal Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.